News

Current Location:Home - News

   
The total investment is 3.05 billion yuan! The foundation laying and commencement of TUL (Gaolan Port) project
The total investment is 3.05 billion yuan! The foundation laying and commencement of TUL (Gaolan Port) project

On November 22, 2023, the groundbreaking ceremony for the United Laboratories (Gaolan Port) project was held in Nanshui Town, Jinwan District, Zhuhai City. More than 200 people, including leaders of the Zhuhai Municipal Government, senior executives and emplo...

Date: 2024-03-25 Browse:71
TUL won the "ESG Special Commendation Award"
TUL won the "ESG Special Commendation Award"

On November 9, 2023, the TVB Environmental, Social and Governance Awards 2023 ceremony was held in Hong Kong, and The United Laboratories International Holdings Limited (3933. HK) was awarded the ESG Special Commendation Award.

Date: 2024-03-25 Browse:53
Chairman of the Board of Directors of TUL, Tsoi Hoi Shan, visited and exchanged ideas with Wens Group in Guangdong
Chairman of the Board of Directors of TUL, Tsoi Hoi Shan, visited and exchanged ideas with Wens Group in Guangdong

On October 31, 2023, Tsoi Hoi Shan, Chairman of the Board of Directors of TUL, and Liu Hongchi, General Manager of The United Animal Healthcare (Inner Mongolia) Co., Ltd., visited and inspected the headquarters of Wens Group in Guangdong.

Date: 2024-03-25 Browse:60
Tsoi Hoi Shan is honored to serve as Honorary President of Jinwan Hong Kong & Macau Chamber of Commerce
Tsoi Hoi Shan is honored to serve as Honorary President of Jinwan Hong Kong & Macau Chamber of Commerce

On October 28, 2023, the inaugural ceremony of the first Executive Council of the Jinwan Hong Kong & Macau Chamber of Commerce was held in Hong Kong, and the Chairman of the Board of Directors of the United Laboratories, Tsoi Hoi Shan, was honored as the Hono...

Date: 2024-03-25 Browse:55
TUL Amoxicillin Capsules (specification: 0.5g) passed the consistency evaluation of generic drugs
TUL Amoxicillin Capsules (specification: 0.5g) passed the consistency evaluation of generic drugs

Recently, TUL obtained the Notice of Approval of Supplementary Drug Application for Amoxicillin Capsules (specification: 0.5g) approved and issued by NMPA, which approved this product to pass the quality and efficacy consistency evaluation of generic drugs.

Date: 2023-04-26 Browse:607
2022 Annual Results Announcement
2022 Annual Results Announcement

Date: 2023-04-20 Browse:0
TUL ranked No.21 in "top 100 pharmaceutical enterprises of China in 2019" Date: 2020-09-17 Browse:1581

On August 30, 2020, the 37th national pharmaceutical industry information annual conference, sponsored by China Pharmaceutical Industry Information Center, was grandly opened in Zhuhai. The conference solemnly released the list of top 100 pharmaceutical enter...

TUL ranked No.18th in top 100 chemical pharmaceutical enterprises in China in 2019 Date: 2020-09-17 Browse:1533

The national pharmacy week, the annual meeting of China's top 100 pharmaceutical industry and the annual meeting of China's pharmaceutical Internet economy were held in Kunming yun'anHuidu International Conference Center from August 25 to 28, 2020. At the mee...

TUL was listed in the list of China's pharmaceutical health with the most investment potential in 2019-2020 Date: 2020-09-17 Browse:1539

On August 13, the list of "China's medical and health investment value ranking list in 2019-2020" was officially announced by xinkangjie. The enterprises participating in the selection are Chinese medical and health enterprises listed in A shares, Hong Kong s...

TUL won the "best IR team" of Sina Financial Jinqilin Hong Kong stock value list in 2020 Date: 2020-09-17 Browse:1564

On August 18, the results of the "2020 Jinqilin Hong Kong stock value list" sponsored by Sina Finance and economics were announced. With its positive capital market performance, The United Laboratories International Holdings Co., Ltd. (3933. HK) was awarded t...

TUL has been awarded as "Guangdong Province contract abiding and trustworthy enterprise" for 6 consecutive years Date: 2020-09-17 Browse:1533

On June 1, Zhuhai United Laboratories Co., Ltd., Zhuhai United Laboratories Co., Ltd.(Zhongshan Branch), Zhuhai United Laboratories Trading Company Limited and Zhuhai United Laboratories (Wanbang) Co., Ltd. were awarded the title of "Guangdong Province contra...

Zhuhai United Laboratories Trading Company Limited was awarded "group member of the Second Council of Zhuhai People's Association for friendship with foreign countries" Date: 2020-09-17 Browse:1850

On July 27, Zhuhai United Laboratories Trading Company Limited received the letter of appointment from Zhuhai People's Association for friendship with foreign countries and was officially appointed as a group member of the Second Council of them.The Zhuhai Pe...

TUL was selected into Hang Sengindex of "Shanghai, Shenzhen and Hong Kong innovative drug selection 50". Date: 2020-09-17 Browse:1538

HSI announced earlier that the results of half year index review of Hang Seng Shanghai, Shenzhen and Hong Kong innovative drug selection 50 index as of April 30, 2020, including Livzon (01513), Genscript (01548), HANSOH Pharmaceutical (03692), TUL (03933), et...

TUL was awarded "Guangdong Province legal culture construction demonstration enterprise" Date: 2020-09-17 Browse:1458

On April 21, the Provincial Department of justice, the Provincial Department of industrial information, the provincial state owned assets supervision and Administration Commission, the Provincial Federation of industry and commerce, the Provincial Federation ...

TUL won the "top 10 comprehensive competitive enterprises" of Zhuhai pharmaceutical in the 40th anniversary of reform and opening up in 2019 Date: 2020-09-17 Browse:1498

On May 28, the third general meeting of the second Zhuhai pharmaceutical circulation industry association was held in Zhuhai blue ocean financial center. Attending the meeting were members of the Standing Committee of the CPPCC Zhuhai Municipal Committee, rel...

Class 1 new drugs independently developed by TUL enter clinical practice Date: 2020-09-17 Browse:1599

Recently, Zhuhai United Laboratories Co., Ltd. received the "Notice of clinical trial" issued by the State Drug Administration, approving the company's class 1 innovative drug wxsh0150 tablets for clinical trial, with the acceptance number of [cxhl2000041; cx...

Page: 6/11 Atotalof 108 records Previous page 2 3 4 5 6 7 8 9 10 Next Page